VarCov Co’s Bicara Therapeutics BCAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$208K Buy
11,159
+1,060
+10% +$26.5K 0.1% 307
2026
Q2
$300K Sell
10,099
-3,193
-24% -$71.3K 0.11% 263
2026
Q1
$264K Sell
13,292
-2,361
-15% -$40.6K 0.1% 300
2025
Q4
$263K Buy
+15,653
New +$267K 0.1% 322

Other funds holding BCAX

VarCov Co's BCAX Position: Q3 2026 in Review

VarCov Co increased its Bicara Therapeutics (BCAX) stake by 10% in Q3 2026, buying an estimated $26.5K and bringing the position to 11,159 shares worth $208K. The position accounts for 0.1% of the portfolio, ranked #307.

VarCov Co first reported a position in BCAX in Q4 2025 and has held it in 4 quarters since. The position peaked at $300K in Q2 2026. 169 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.

  • VarCov Co held 11,159 shares of Bicara Therapeutics worth $208K as of Q3 2026.
  • VarCov Co bought 1,060 Bicara Therapeutics shares in Q3 2026, an estimated $26.5K.
  • Bicara Therapeutics made up 0.1% of VarCov Co's portfolio in Q3 2026, its #307 holding.
  • VarCov Co first reported a position in Bicara Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • VarCov Co's Bicara Therapeutics position peaked at $300K in Q2 2026.
  • 169 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.